Skip to content

Bendit®21 Microcatheter BDT21157U2Recalls & reported problems

Bend It Technologies Ltd · The Bendit®21 Microcatheter is intended for use in accessing target locations in the peripheral, coronary, and neuro vasculature and can be used to deliver both diagnostic agents, such as contrast media, and therapeutic devices. Use only contrast media and therapeutic devices that have been cleared or approved for use in the intended target area. · Class 2

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 17290018072049), received between Nov 20, 2023 and Jul 16, 2024 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Break” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 2 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 1 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Break3

Patient problems

  • No Clinical Signs, Symptoms or Conditions3

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 16, 2024Break; Break

    YOUNG FEMALE WITH A RIGHT SUPERIOR HYPOPHESEAL SEGMENT ANEURYSM. ACCESS VIA RADIAL APPROACH USING A RIST CATHETER. WHEN TRYING TO NAVIGATE THE ANEURYSM FROM CAVERNOUS TO SUP HYP, LACK OF RESPONSE ON ADVANCING OR PULLING BACK THE DEVICE WAS FELT. WHEN THE WHOLE SYSTEM WAS RETRIEVED, A FRACTURE WAS NOTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19757149 ↗
  • MalfunctionNov 21, 2023Break; Break

    PATIENT WITH A GIANT CAVERNOUS SINUS ANEURYSM. RADIAL ACCESS WITH THE BENDIT21 MICROCATHETER WAS EMPLOYED TO REACH THE ANEURYSM. DURING THE ACCESS ATTEMPT, THE CATHETER BROKE AND WHILE REMOVING A DISTAL SECTION OF THE CATHETER REMAINED WITHIN THE FOREARM AND WAS REMOVED USING A SNARE. THE BENDIT21 MICROCATHETER IS INTENDED FOR FEMORAL ACCESS, THE RISK PROFILE OF USING THE DEVICE IN RADIAL ACCESS IS NOT KNOWN. THE PHYSICIAN TRANSFERRED TO FEMORAL ACCESS AND USED A SECOND BENDIT21 CATHETER WHICH SUCCEEDED TO OBTAIN ACCESS TO THE ANEURYSM AND ENABLE FURTHER TREATMENT OF THE PATIENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18182213 ↗
  • MalfunctionNov 20, 2023Break; Break

    THE BENDIT21 MICROCATHETER WAS USED TO ACCESS THE ACA ANEURYSM ANEURYSM IN PATIENT WITH HIGHLY TORTUOUS BLOOD VESSEL ANATOMY. DUE TO THE EXTREMELY HIGH TORTUOSITY A SIGNIFICANT ARTICULATION AND TORQUING FORCES WERE APPLIED TO THE CATHETER RESULTING IN CATHETER BREAKAGE. CATHETER WAS REMOVED WITH NO HARM TO THE PATIENT.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 18178687 ↗

Other Catheter, Percutaneous, Neurovasculature devices

All Catheter, Percutaneous, Neurovasculature devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page